Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
A Gustav Klimt painting is now the most expensive piece of modern art sold at auction. The fascinating history behind the $236 million 'Portrait of Elisabeth Lederer.'- Sought-After Extravagance Ocean side Objections for a Lovely Escape
- Bother Control Administrations for 2024: Decide for Your Home
- U.K. blocks Kanye West from entering Britain to headline now canceled festival: What led to the ban
- This widow influencer is using jokes to cope after her husband's death. It's OK if people don't get it.
- Schools to start reopening after Nigeria mass abduction
- Vote In favor of Your Number one Sort Of Blossoms
- 'Peaky Blinders: The Immortal Man' teaser trailer reveals Cillian Murphy's Tommy Shelby back in action
- JW Marriott Tokyo: an elegant retreat amid whirlwind of the city
